Nephrodite - Crunchbase Company Profile & Funding

Q: Where is Nephrodite's headquarters?

Nephrodite is located in Atlanta, Georgia, United States.

Overview

Nephrodite

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Nephrodite

CB Rank

142457

Nephrodite Inc. creates an implantable dialysis device combining hemodialysis and peritoneal dialysis for end-stage renal disease.

Private

Atlanta, Georgia, United States

11-50

nephrodite.com

Health Care

Manufacturing

Medical Device

Key People

Hiep T. Nguyen: CSO & Co-Founder
Nikhil L. Shah: CEO & Co-Founder

Details

Legal Name

Nephrodite Inc.

Operating Status

Active

Company Type

For Profit

Founders

Hiep T. Nguyen, Nikhil L. Shah, Vikram Vijayvergiya

About the Company

Nephrodite Inc. develops an implantable continuous dialysis hemofiltration device that combines hemodialysis and peritoneal dialysis. This innovative solution aims to revolutionize kidney care by providing a patient-inspired dialysis option, enhancing the quality of life for individuals with end-stage renal disease. The device is designed to be

both implantable and wearable, offering a new approach to renal disease treatment.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Holly™

An implantable continuous dialysis device combining hemodialysis and peritoneal dialysis to provide renal replacement therapy for end-stage renal disease patients.

Holly system

An implantable continuous dialysis device providing sustained toxin clearance and fluid balance for end-stage kidney disease patients.